|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-12-25
|
|
pubmed:abstractText |
BMP-2 can replace autogenous bone grafting in lumbar one-level anterior lumbar interbody fusions (ALIF). The current G-DRG system does not reimburse the upfront price of 2,970 euro per BMP-2 application for hospitals in Germany. The purpose of the current study was to create a health economic model to evaluate the financial savings for health care providers (hospitals) and health care payers (health care insurance) that can be achieved by the use of BMP-2 in spine surgery.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0044-3220
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
144
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-82
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:17187331-Bone Morphogenetic Protein 2,
pubmed-meshheading:17187331-Bone Morphogenetic Proteins,
pubmed-meshheading:17187331-Cost Savings,
pubmed-meshheading:17187331-Diagnosis-Related Groups,
pubmed-meshheading:17187331-Disability Evaluation,
pubmed-meshheading:17187331-Germany,
pubmed-meshheading:17187331-Health Care Costs,
pubmed-meshheading:17187331-Hospital Charges,
pubmed-meshheading:17187331-Humans,
pubmed-meshheading:17187331-Insurance, Health, Reimbursement,
pubmed-meshheading:17187331-Lumbar Vertebrae,
pubmed-meshheading:17187331-Models, Economic,
pubmed-meshheading:17187331-National Health Programs,
pubmed-meshheading:17187331-Spinal Fusion,
pubmed-meshheading:17187331-Transforming Growth Factor beta
|
|
pubmed:articleTitle |
[Health-economic considerations for the use of BMP-2 for spinal surgery in Germany].
|
|
pubmed:affiliation |
Klinik für Unfallchirurgie, Universitätsklinikum Giessen-Marburg, Standort Giessen, Germany. volker.alt@chiru.med.uni-giessen.de
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
